FDA inspection
Dong IL Pharm Co., Ltd.: FDA inspection ending Nov 3, 2023
FDA inspection 1225010 · No Action Indicated (NAI) · Eumseong
Key facts
| Inspection ID | 1225010 |
|---|---|
| Firm | Dong IL Pharm Co., Ltd. |
| FEI number | 3015116573 |
| Address | 26 Rinosandan-Gil, Maengdong-Myeon |
| City | Eumseong |
| Country | Korea (the Republic of) |
| Fiscal year | 2024 |
| Inspection end date | Nov 3, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data